{"id":"https://openalex.org/W2090401250","doi":"https://doi.org/10.1080/10428190802428369","title":"Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers ofin vivoresponse","display_name":"Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers ofin vivoresponse","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2090401250","doi":"https://doi.org/10.1080/10428190802428369","mag":"2090401250","pmid":"https://pubmed.ncbi.nlm.nih.gov/19021061"},"language":"en","primary_location":{"id":"doi:10.1080/10428190802428369","doi":"https://doi.org/10.1080/10428190802428369","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428190802428369","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052154203","display_name":"Jane Houldsworth","orcid":"https://orcid.org/0000-0002-6781-1700","observed_orcids":["https://orcid.org/0000-0002-6781-1700"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane Houldsworth","raw_affiliation_strings":["Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA","Cell Biology Program","Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Cell Biology Program","institution_ids":[]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023808318","display_name":"Marina Petlakh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Petlakh","raw_affiliation_strings":["Cell Biology Program"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Biology Program","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016883047","display_name":"Adam B. Olshen","orcid":"https://orcid.org/0000-0002-8998-4514","observed_orcids":["https://orcid.org/0000-0002-8998-4514"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam B. Olshen","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064232878","display_name":"R.S.K. Chaganti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"R. S. K. Chaganti","raw_affiliation_strings":["Cell Biology Program; Department of Medicine","Cell Biology Program","Department of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Biology Program; Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"Cell Biology Program","institution_ids":[]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5064232878"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7094,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.74849317,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"49","issue":"11","first_page":"2170","last_page":"2180"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/p53-signaling-pathway","display_name":"p53 pathway","score":0.7720000147819519},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8859999775886536},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8690000176429749},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.8270000219345093},{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.8199999928474426},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/anthracycline-response","display_name":"anthracycline response","score":0.6579999923706055},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.7099999785423279},{"id":"https://openalex.org/keywords/lymphoma-cell-lines","display_name":"lymphoma cell lines","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7700057029724121},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7512993812561035},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6451947689056396},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5893948674201965},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5228174924850464},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5216051340103149},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5071063041687012},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.44404253363609314},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4243290424346924},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3068158030509949},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2722933888435364},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2157449722290039},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13537967205047607},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.09354144334793091},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049490","descriptor_name":"Systems Biology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/10428190802428369","doi":"https://doi.org/10.1080/10428190802428369","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428190802428369","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:19021061","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19021061","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W417406195","https://openalex.org/W1499230593","https://openalex.org/W1535776410","https://openalex.org/W1573954848","https://openalex.org/W1579102917","https://openalex.org/W1759028523","https://openalex.org/W1931280990","https://openalex.org/W1965688832","https://openalex.org/W1976564639","https://openalex.org/W1977534321","https://openalex.org/W1978959944","https://openalex.org/W2005486228","https://openalex.org/W2022221742","https://openalex.org/W2022588086","https://openalex.org/W2026182485","https://openalex.org/W2028096444","https://openalex.org/W2029304297","https://openalex.org/W2030439968","https://openalex.org/W2035271331","https://openalex.org/W2036575025","https://openalex.org/W2041622856","https://openalex.org/W2055878807","https://openalex.org/W2057068754","https://openalex.org/W2062290101","https://openalex.org/W2063514430","https://openalex.org/W2067175003","https://openalex.org/W2068857334","https://openalex.org/W2071169664","https://openalex.org/W2077832231","https://openalex.org/W2081098333","https://openalex.org/W2085592081","https://openalex.org/W2105381419","https://openalex.org/W2107831273","https://openalex.org/W2122347701","https://openalex.org/W2130158125","https://openalex.org/W2131922930","https://openalex.org/W2136426653","https://openalex.org/W2139954541","https://openalex.org/W2143811153","https://openalex.org/W2146573874","https://openalex.org/W2147246240","https://openalex.org/W2150382709","https://openalex.org/W2150926065","https://openalex.org/W2163498786","https://openalex.org/W2163990748","https://openalex.org/W2164134168","https://openalex.org/W2168831854","https://openalex.org/W2170955681","https://openalex.org/W2170989872","https://openalex.org/W2171806736","https://openalex.org/W2320028767"],"related_works":["https://openalex.org/W2558446477","https://openalex.org/W4396622445","https://openalex.org/W4310369244","https://openalex.org/W3215790713","https://openalex.org/W2127356664","https://openalex.org/W2167115151","https://openalex.org/W7223195185","https://openalex.org/W2588407924","https://openalex.org/W2264917015","https://openalex.org/W2979593466"],"abstract_inverted_index":{"The":[0,71],"principal":[1],"curative":[2],"agent":[3],"in":[4,29,34,58,88,117,157,170,173],"the":[5,17,30,48,83,89,123,133,139,166,190],"front-line":[6],"treatment":[7],"of":[8,32,54,60,82,128,142,145,151,168,197],"patients":[9],"with":[10,45,63,120,132,149,162],"diffuse":[11],"large":[12],"B-cell":[13],"lymphoma":[14],"(DLBCL)":[15],"is":[16,175],"anthracycline,":[18],"doxorubicin.":[19,143],"To":[20],"define":[21],"pathways":[22,183],"that":[23,67,156],"may":[24],"have":[25],"a":[26,107],"functional":[27],"role":[28],"response":[31,50,167],"DLBCL":[33,40,169],"vivo":[35,158,171],"to":[36],"doxorubicin-based":[37],"therapies,":[38],"seven":[39],"cell":[41,75],"lines":[42,76],"were":[43,68,101],"treated":[44],"doxorubicin":[46,131],"and":[47,78,96,172,181,194],"cellular":[49],"evaluated.":[51],"Expression":[52],"profiling":[53],"responses":[55],"revealed":[56],"changes":[57],"levels":[59],"genes":[61],"consistent":[62],"discrete":[64],"pathway":[65,85,113],"activation":[66,81,114],"confirmed":[69],"functionally.":[70],"two":[72],"most":[73,124],"sensitive":[74],"(Ly3":[77],"Ly10)":[79],"displayed":[80,122],"TP53":[84,99],"but":[86],"not":[87,187],"remaining":[90],"five":[91],"(Ly1,":[92],"Ly2,":[93],"Ly4,":[94],"Ly7":[95],"Ly8),":[97],"where":[98],"mutations":[100],"identified.":[102],"In":[103],"this":[104],"latter":[105],"group,":[106],"G2/M":[108],"delay":[109],"was":[110,115,147,159],"invoked.":[111],"NF-kappaB":[112],"evident":[116],"Ly1":[118,129],"which":[119,184],"Ly4":[121,146],"chemoresistant":[125],"response.":[126],"Treatment":[127],"after":[130],"proteasomic":[134],"inhibitor,":[135],"bortezomib,":[136],"additively":[137],"increased":[138],"cytotoxic":[140],"effect":[141],"Chemoresistance":[144],"associated":[148],"loss":[150],"chromosome":[152],"2":[153],"(0-9":[154],"Mbp)":[155],"highly":[160],"correlated":[161],"adverse":[163],"outcome.":[164],"Thus,":[165],"vitro":[174],"defined":[176],"by":[177],"several":[178],"distinct":[179],"molecular":[180],"genetic":[182,195],"is,":[185],"perhaps,":[186],"surprising":[188],"given":[189],"heterogeneous":[191],"clinical,":[192],"morphologic":[193],"nature":[196],"DLBCL.":[198]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}